MedPath

ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS

ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS

Approved
DIN Number

02466783

Drug Class

Human

Market Date

Oct 30, 2017

Company
HC

glenmark pharmaceuticals canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02466783
AIG Number0250721002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
P01BB51 PROGUANIL AND ATOVAQUONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:30.92
Health Canada Classification

ACTIVE INGREDIENTS (2)

ATOVAQUONEActive
Strength: 250 MG
Monograph: ATOVAQUONE
PROGUANIL HYDROCHLORIDEActive
Strength: 100 MG
Monograph: PROGUANIL HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.